Related references
Note: Only part of the references are listed.PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance
Alessandra Dondero et al.
ONCOIMMUNOLOGY (2016)
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity
Christine Pasero et al.
CANCER RESEARCH (2016)
High-throughput proteomics reveal alarmins as amplifiers of tissue pathology and inflammation after spinal cord injury
Athanasios Didangelos et al.
SCIENTIFIC REPORTS (2016)
Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration
Christine Mayer et al.
JOURNAL OF CANCER (2016)
Natural killer cell memory in infection, inflammation and cancer
Adelheid Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells
M. Ricciardi et al.
BRITISH JOURNAL OF CANCER (2015)
High-mobility group Box 1: A novel inducer of the epithelial-mesenchymal transition in colorectal carcinoma
Lingyin Zhu et al.
CANCER LETTERS (2015)
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells
Xiao-Hui Chen et al.
MOLECULAR IMMUNOLOGY (2015)
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment
Monica Parodi et al.
ONCOIMMUNOLOGY (2015)
Interferon-γ-induced activation of JAK1 and JAK2 suppresses tumor cell susceptibility to NK cells through upregulation of PD-L1 expression
Roberto Bellucci et al.
ONCOIMMUNOLOGY (2015)
Pnenotype switching in melanoma: implications for progression and therapy
Frederic Zhentao Li et al.
FRONTIERS IN ONCOLOGY (2015)
Mature Cytotoxic CD56(bright)/CD16(+) Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic Melanoma
Meriem Messaoudene et al.
CANCER RESEARCH (2014)
Metalloprotease-Mediated Tumor Cell Shedding of B7-H6, the Ligand of the Natural Killer Cell-Activating Receptor NKp30
Eva Schlecker et al.
CANCER RESEARCH (2014)
Phenotype Switching: Tumor Cell Plasticity as a Resistance Mechanism and Target for Therapy
Kristel Kemper et al.
CANCER RESEARCH (2014)
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells
Francesca Bellora et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Effect of tumor cells and tumor microenvironment on NK-cell function
Massimo Vitale et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
Paolo Carrega et al.
JOURNAL OF IMMUNOLOGY (2014)
Evaluation of in vitro properties of predicted kinases that phosphorylate serine residues within nuclear localization signal 1 of high mobility group box 1
Junichi Taira et al.
JOURNAL OF PEPTIDE SCIENCE (2014)
The Association of HMGB1 Expression with Clinicopathological Significance and Prognosis in Hepatocellular Carcinoma: A Meta-Analysis and Literature Review
Lu Zhang et al.
PLOS ONE (2014)
JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
Ben Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Development of human natural killer cells and other innate lymphoid cells
Elisa Montaldo et al.
SEMINARS IN IMMUNOLOGY (2014)
Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients
Talib Hassan Ali et al.
NATURE COMMUNICATIONS (2014)
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Limo Chen et al.
NATURE COMMUNICATIONS (2014)
Overexpression of HMGB1 in melanoma predicts patient survival and suppression of HMGB1 induces cell cycle arrest and senescence in association with p21 (Waf1/Cip1) up-regulation via a p53-independent, Sp1-dependent pathway
Qingling Li et al.
ONCOTARGET (2014)
Molecular bases for the regulation of NIKG2D ligands in cancer
Leticia Huergo-Zapico et al.
FRONTIERS IN IMMUNOLOGY (2014)
Natural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approaches
Cristina Bottino et al.
FRONTIERS IN IMMUNOLOGY (2014)
TLR/NCR/KIR: which one to use and when?
Simona Sivori et al.
FRONTIERS IN IMMUNOLOGY (2014)
Directed Phenotype Switching as an Effective Antimelanoma Strategy
Magali Saez-Ayala et al.
CANCER CELL (2013)
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
Sylvie Rusakiewicz et al.
CANCER RESEARCH (2013)
Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Romain Remark et al.
CLINICAL CANCER RESEARCH (2013)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Epithelial-mesenchymal plasticity in carcinoma metastasis
Jeff H. Tsai et al.
GENES & DEVELOPMENT (2013)
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
Martin Franz Sprinzl et al.
HEPATOLOGY (2013)
Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients
Yamila S. Rocca et al.
INNATE IMMUNITY (2013)
Epithelial-Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor
Alejandro Lopez-Soto et al.
JOURNAL OF IMMUNOLOGY (2013)
Neuroblastoma-Derived TGF-β1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2013)
M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
Chao-Ying Liu et al.
LABORATORY INVESTIGATION (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1
J. R. van Beijnum et al.
ONCOGENE (2013)
Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection
Stephanie Jost et al.
RETROVIROLOGY (2013)
HMGB1: the central cytokine for all lymphoid cells
Guanqiao Li et al.
FRONTIERS IN IMMUNOLOGY (2013)
Regulatory networks defining EMT during cancer initiation and progression
Bram De Craene et al.
NATURE REVIEWS CANCER (2013)
Innate lymphoid cells - a proposal for uniform nomenclature
Hergen Spits et al.
NATURE REVIEWS IMMUNOLOGY (2013)
The speed of change: towards a discontinuity theory of immunity?
Thomas Pradeu et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells
Hanna Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
NMDA Receptors in Immune Competent Cells
A. A. Boldyrev et al.
BIOCHEMISTRY-MOSCOW (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Melanoma Cells Inhibit NK Cell Functions-Letter
Giuseppe Sconocchia et al.
CANCER RESEARCH (2012)
Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
Gabriella Pietra et al.
CANCER RESEARCH (2012)
Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
Gulsun Erdag et al.
CANCER RESEARCH (2012)
MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang et al.
CELL (2012)
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor
Mirna Balsamo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
Wei Yan et al.
HEPATOLOGY (2012)
Chemokines and NK cells: Regulators of development, trafficking and functions
Giovanni Bernardini et al.
IMMUNOLOGY LETTERS (2012)
The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses
Russell K. Pachynski et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
Milena Schiraldi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
Emilie Venereau et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The IKKα-Dependent NF-κB p52/RelB Noncanonical Pathway Is Essential To Sustain a CXCL12 Autocrine Loop in Cells Migrating in Response to HMGB1
Richard R. Kew et al.
JOURNAL OF IMMUNOLOGY (2012)
Human NK Cells Induce Neutrophil Apoptosis via an NKp46-and Fas-Dependent Mechanism
Fredrik B. Thoren et al.
JOURNAL OF IMMUNOLOGY (2012)
The Effect of HMGB1, a Damage-Associated Molecular Pattern Molecule, on Polymorphonuclear Neutrophil Migration Depends on Its Concentration
Florence Berthelot et al.
JOURNAL OF INNATE IMMUNITY (2012)
Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer
Guo-Liang Yang et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Poly(ADP-Ribosyl)ation of High Mobility Group Box 1 (HMGB1) Protein Enhances Inhibition of Efferocytosis
Kasey Davis et al.
MOLECULAR MEDICINE (2012)
High Mobility Group Box Protein 1 (HMGB1)-Partner Molecule Complexes Enhance Cytokine Production by Signaling Through the Partner Molecule Receptor
Hulda Sigridur Hreggvidsdottir et al.
MOLECULAR MEDICINE (2012)
被撤回的出版物: Redox Modification of Cysteine Residues Regulates the Cytokine Activity of High Mobility Group Box-1 (HMGB1) (Publication with Expression of Concern. See vol. 26, 2020) (Retracted article. See vol. 26, 2020)
Huan Yang et al.
MOLECULAR MEDICINE (2012)
Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
Shigeki Chiba et al.
NATURE IMMUNOLOGY (2012)
HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer
Clarissa A. Wild et al.
ORAL ONCOLOGY (2012)
Potentiation of NMDA Receptor-Dependent Cell Responses by Extracellular High Mobility Group Box 1 Protein
Marco Pedrazzi et al.
PLOS ONE (2012)
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
Janis M. Taube et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Interaction between uric acid and HMGB1 translocation and release from endothelial cells
May M. Rabadi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
Sophia Platonova et al.
CANCER RESEARCH (2011)
Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines
Niels Halama et al.
CLINICAL CANCER RESEARCH (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
DNA Alkylating Therapy Induces Tumor Regression through an HMGB1-Mediated Activation of Innate Immunity
Jennifer L. Guerriero et al.
JOURNAL OF IMMUNOLOGY (2011)
Natural Killer Cells and Solid Tumors
Ana Stojanovic et al.
JOURNAL OF INNATE IMMUNITY (2011)
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
Nicolas F. Delahaye et al.
NATURE MEDICINE (2011)
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Eric Vivier et al.
SCIENCE (2011)
High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts
Heidi Wahamaa et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
Benjamin Toh et al.
PLOS BIOLOGY (2011)
High-Mobility Group Box 1-Mediated Matrix Metalloproteinase-9 Expression in Non-Small Cell Lung Cancer Contributes to Tumor Cell Invasiveness
Po-Len Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Regulation of human NK-cell cytokine and chemokine production by target cell recognition
Cyril Fauriat et al.
BLOOD (2010)
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
Niklas K. Bjorkstrom et al.
BLOOD (2010)
CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset
Sandra Lopez-Verges et al.
BLOOD (2010)
Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma
Xingjun Yao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Analysis of Nuclear High Mobility Group Box 1 (HMGB1)-Binding Proteins in Colon Cancer Cells: Clustering with Proteins Involved in Secretion and Extranuclear Function
Hanna Lee et al.
JOURNAL OF PROTEOME RESEARCH (2010)
HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
D. Tang et al.
ONCOGENE (2010)
HMGB1 Attenuates Anti-Metastatic Defense of the Lymph Nodes in Colorectal Cancer
Yukiko Moriwaka et al.
PATHOBIOLOGY (2010)
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
New views on natural killer cell-based immunotherapy for melanoma treatment
Shannon Burke et al.
TRENDS IN IMMUNOLOGY (2010)
Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas
Guoqiang Bao et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2010)
Regulation of HMGB1 release by autophagy
Jacqueline Thorburn et al.
AUTOPHAGY (2009)
Cancer Metastasis Is Accelerated through Immunosuppression during Snail-induced EMT of Cancer Cells
Chie Kudo-Saito et al.
CANCER CELL (2009)
Epithelial-Mesenchymal Transitions in Development and Disease
Jean Paul Thiery et al.
CELL (2009)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
Tadepally Lakshmikanth et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
HMGB1 Is Phosphorylated by Classical Protein Kinase C and Is Secreted by a Calcium-Dependent Mechanism
Young Joo Oh et al.
JOURNAL OF IMMUNOLOGY (2009)
The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation
Hulda Sigridur Hreggvidsdottir et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Mirna Balsamo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Human gingival fibroblasts release high-mobility group box-1 protein through active and passive pathways
K. Feghali et al.
ORAL MICROBIOLOGY AND IMMUNOLOGY (2009)
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
Kornelia Polyak et al.
NATURE REVIEWS CANCER (2009)
Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56BrightCD16- cells and display an impaired capability to kill tumor cells
Paolo Carrega et al.
CANCER (2008)
In vivo switching of human melanoma cells between proliferative and invasive states
Keith S. Hoek et al.
CANCER RESEARCH (2008)
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Marco Wendel et al.
CANCER RESEARCH (2008)
Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells
Keisuke Oguma et al.
EMBO JOURNAL (2008)
Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein
Hirotaka Kazama et al.
IMMUNITY (2008)
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Mark J. Smyth
INTERNATIONAL IMMUNOLOGY (2008)
Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages
Xianghong Zhang et al.
JOURNAL OF IMMUNOLOGY (2008)
Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer
G. Esendagli et al.
LUNG CANCER (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
The grateful dead:: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity
Michael T. Lotze et al.
IMMUNOLOGICAL REVIEWS (2007)
miR-200b mediates post-transcriptional repression of ZFHX1B
Nanna Ronbjerg Christoffersen et al.
RNA (2007)
Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils
Ichiaki Ito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues
Silvia Parolini et al.
BLOOD (2007)
Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line
Kunrong Cheng et al.
BIOCHEMICAL PHARMACOLOGY (2007)
HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses
Maciej Kmieciak et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin
De Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression
Francois Ghiringhelli et al.
IMMUNOLOGICAL REVIEWS (2006)
Immunoediting of cancers may lead to epithelial to mesenchymal transition
Keith L. Knutson et al.
JOURNAL OF IMMUNOLOGY (2006)
Role of HMGB1 in apoptosis-mediated sepsis lethality
Shixin Qin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control
Fabrizio Vianello et al.
JOURNAL OF IMMUNOLOGY (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Cutting edge: Extracellular high mobility group box-1 protein is a proangiogenic cytokine
S Mitola et al.
JOURNAL OF IMMUNOLOGY (2006)
Early liaisons between cells of the innate immune system in inflamed peripheral tissues
A Moretta et al.
TRENDS IN IMMUNOLOGY (2005)
NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors
B Le Maux Chansac et al.
JOURNAL OF IMMUNOLOGY (2005)
Laminin-5 with transforming growth factor-β1 induces epithelial to mesenchymal transition in hepatocellular carcinoma
G Giannelli et al.
GASTROENTEROLOGY (2005)
Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2
F Casilli et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Natural killer cells infiltrating colorectal cancer and MHC class I expression
MH Sandel et al.
MOLECULAR IMMUNOLOGY (2005)
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells
S Sivori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Different checkpoints in human NK-cell activation
L Moretta et al.
TRENDS IN IMMUNOLOGY (2004)
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
A Martín-Fontecha et al.
NATURE IMMUNOLOGY (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
The three Es of cancer immunoediting
GP Dunn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1
J Barlic et al.
BLOOD (2003)
NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity
PA Albertsson et al.
TRENDS IN IMMUNOLOGY (2003)
Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion
T Bonaldi et al.
EMBO JOURNAL (2003)
Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells
R Castriconi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions:: a comparison with Snail and E47 repressors
V Bolós et al.
JOURNAL OF CELL SCIENCE (2003)
Gelatinase A (MMP-2), collagenase-2 (MMP-8), and laminin-5 gamma 2-chain expression in murine inflammatory bowel disease (ulcerative colitis)
E Pirila et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
IL-2 and IL-12 alter NK cell responsiveness to IFN-γ-inducible protein 10 by down-regulating CXCR3 expression
DL Hodge et al.
JOURNAL OF IMMUNOLOGY (2002)
Expression of stress-induced MHC class I related chain molecules on human melanoma
CS Vetter et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Regulation of cutaneous malignancy by γδ T cells
M Girardi et al.
SCIENCE (2001)
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion
J Comijn et al.
MOLECULAR CELL (2001)
Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire
JJ Campbell et al.
JOURNAL OF IMMUNOLOGY (2001)
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
MJ Smyth et al.
INTERNATIONAL IMMUNOLOGY (2001)
HMG1 and 2, and related 'architectural' DNA-binding proteins
JO Thomas et al.
TRENDS IN BIOCHEMICAL SCIENCES (2001)
Expression and regulation of chemokine receptors in human natural killer cells
M Inngjerdingen et al.
BLOOD (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
In vivo natural killer cell activities revealed by natural killer cell-deficient mice
S Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression
A Cano et al.
NATURE CELL BIOLOGY (2000)
Share Paper
